GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFQ) » Definitions » 5-Year EBITDA Growth Rate

MedMen Enterprises (MedMen Enterprises) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2023)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises 5-Year EBITDA Growth Rate?

MedMen Enterprises's EBITDA per Share for the three months ended in Mar. 2023 was $-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of MedMen Enterprises's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's 5-Year EBITDA Growth Rate falls into.



MedMen Enterprises 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


MedMen Enterprises  (OTCPK:MMNFQ) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


MedMen Enterprises 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.